Evidence of a cold immunoglobulin M autoantibody against 78-kD platelet glycoprotein in a case of EDTA-dependent pseudothrombocytopenia.
Pseudothrombocytopenia is a phenomenon in which the electronic count shows spuriously low platelet counts in subjects with normal platelet levels. The mechanism of anticoagulant-dependent pseudothrombocytopenia appears to involve cold reactive agglutinins against platelet antigens. The authors report a case of EDTA-dependent pseudothrombocytopenia with evidence of a cold immunoglobulin M antibody against 78-kD platelet membrane glycoprotein (GP). Cell counts were performed by Coulter Counter S-Plus VI (Coulter, Hialeah, FL) in the following anticoagulants: EDTA, Na-citrate, and citrate-theophylline-adenosine-dipyridamole. Anti-platelet antibodies and platelet membrane GP antigens were assayed by an immunofluorescence technique as described by Van dem Borne in 1978. An immunoglobulin M/lambda anti-platelet antibody was found to react in serum as well as in plasma EDTA at room temperature, but not at 37 degrees C. This antibody appeared to be directed against GP78 membrane antigen because this antigen was not detectable by immunofluorescence in platelets collected in EDTA and Na-citrate anticoagulant, whereas a fluorescence signal was revealed in platelets collected in citrate-theophylline-adenosine-dipyridamole. This evidence was confirmed by platelet clumping inhibition tests in which target platelets were pretreated with anti-GP monoclonal antibodies. Clumping in the presence of pseudothrombocytopenia serum was inhibited by anti-GP78kD and anti-GPIIb/IIIa but not by anti-Ib. In this case, GP78 appears to be involved in platelet clumping, together with IIb/IIIa complex. The partial inhibition of the phenomenon observed in citrate-theophylline-adenosine-dipyridamole is probably related to a lower expression of the membrane antigens in platelets collected in this anticoagulant.
De Caterina
M
M
Servizio Speciale di Ematologia, II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, Italy.
Fratellanza
G
G
Grimaldi
E
E
Varriale
V
V
Scopacasa
F
F
Di Maro
G
G
Formisano
S
S
D000373:Agglutinins / Q000276:immunology*; D000925:Anticoagulants / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology*; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000276:immunology; D003080:Cold Temperature; D003450:Cryoglobulins; D004338:Drug Combinations; D004492:Edetic Acid / Q000009:adverse effects*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology*; D008875:Middle Aged; D008970:Molecular Weight; D010976:Platelet Count / Q000187:drug effects; D010980:Platelet Membrane Glycoproteins / Q000737:chemistry / Q000276:immunology*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology
D000373:Agglutinins; D000925:Anticoagulants; D001323:Autoantibodies; D003450:Cryoglobulins; D004338:Drug Combinations; D007075:Immunoglobulin M; D010980:Platelet Membrane Glycoproteins; C029443:cold agglutinins; D004492:Edetic Acid